{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:24Z","timestamp":1789560144794,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1038\/mtna.2016.19","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T11:30:48Z","timestamp":1459855848000},"page":"e307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes"],"prefix":"10.1016","volume":"5","author":[{"given":"Cristina","family":"Chamorro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"Menc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Almarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"B\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sallach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hausser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Murillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2016.19_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"key":"10.1038\/mtna.2016.19_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nprot.2011.301","article-title":"AAV-mediated gene targeting methods for human cells","volume":"6","author":"Khan","year":"2011","journal-title":"Nat Protoc"},{"key":"10.1038\/mtna.2016.19_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/mt.2014.14","article-title":"Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy","volume":"22","author":"Sallach","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.15252\/emmm.201303374","article-title":"Targeted gene therapy and cell reprogramming in Fanconi anemia","volume":"6","author":"Rio","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1038\/mtna.2016.19_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.stem.2015.03.009","article-title":"Clinical translation of TALENS: Treating SCID-X1 by gene editing in iPSCs","volume":"16","author":"Biffi","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1038\/mtna.2016.19_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2016.19_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mtna.2016.19_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.mt.6300339","article-title":"Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta","volume":"16","author":"Chamberlain","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/mt.2010.102","article-title":"Efficient KRT14 targeting and functional characterization of transplanted human keratinocytes for the treatment of epidermolysis bullosa simplex","volume":"18","author":"Petek","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/mt.2013.290","article-title":"Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant","volume":"22","author":"Melo","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/hum.2011.140","article-title":"Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors","volume":"23","author":"H\u00e4ndel","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2016.19_bib12","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/MCB.23.10.3550-3557.2003","article-title":"Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks","volume":"23","author":"Miller","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1038\/mtna.2016.19_bib13","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1128\/MCB.23.10.3558-3565.2003","article-title":"Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks","volume":"23","author":"Porteus","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1038\/mtna.2016.19_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJMcibr1414709","article-title":"A biologic Velcro patch","volume":"372","author":"Tolar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2016.19_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.2010.09713.x","article-title":"The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation","volume":"163","author":"Esc\u00e1mez","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/mtna.2016.19_bib16","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/mt.2013.111","article-title":"Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients","volume":"21","author":"Ousterout","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/mt.2014.234","article-title":"Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases","volume":"23","author":"Ousterout","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/geno.1994.1239","article-title":"Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene","volume":"21","author":"Christiano","year":"1994","journal-title":"Genomics"},{"issue":"Web Server issue","key":"10.1038\/mtna.2016.19_bib19","doi-asserted-by":"crossref","first-page":"W117","DOI":"10.1093\/nar\/gks608","article-title":"TAL effector-nucleotide targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction","volume":"40","author":"Doyle","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.19_bib20","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/nar\/gkr218","article-title":"Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting","volume":"39","author":"Cermak","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.19_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtna.2016.19_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2144\/04364PF01","article-title":"Mutation detection using Surveyor nuclease","volume":"36","author":"Qiu","year":"2004","journal-title":"Biotechniques"},{"key":"10.1038\/mtna.2016.19_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/exd.12203","article-title":"Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo","volume":"22","author":"Chamorro","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1038\/mtna.2016.19_bib24","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mtna.2016.19_bib25","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/dvdy.24183","article-title":"Poly peak parser: Method and software for identification of unknown indels using sanger sequencing of polymerase chain reaction products","volume":"243","author":"Hill","year":"2014","journal-title":"Dev Dyn"},{"key":"10.1038\/mtna.2016.19_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/1523-1747.ep12560795","article-title":"Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa","volume":"90","author":"Leigh","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mtna.2016.19_bib27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.mt.6300238","article-title":"Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy","volume":"15","author":"Larcher","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.15252\/emmm.201404353","article-title":"A single epidermal stem cell strategy for safe ex vivo gene therapy","volume":"7","author":"Droz-Georget Lathion","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1038\/mtna.2016.19_bib29","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/mt.2013.143","article-title":"Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination","volume":"21","author":"Coluccio","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib30","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/mt.2014.187","article-title":"Long-term skin regeneration from a gene-targeted human epidermal stem cell clone","volume":"22","author":"Duarte","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib31","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib32","doi-asserted-by":"crossref","first-page":"264ra163","DOI":"10.1126\/scitranslmed.3009540","article-title":"Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Sebastiano","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2016.19_bib33","doi-asserted-by":"crossref","first-page":"264ra164","DOI":"10.1126\/scitranslmed.3009342","article-title":"Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa","volume":"6","author":"Umegaki-Arao","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2016.19_bib34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ng1380","article-title":"Adeno-associated virus vectors integrate at chromosome breakage sites","volume":"36","author":"Miller","year":"2004","journal-title":"Nat Genet"},{"key":"10.1038\/mtna.2016.19_bib35","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/mt.2010.35","article-title":"Frequent endonuclease cleavage at off-target locations in vivo","volume":"18","author":"Petek","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2016.19_bib36","doi-asserted-by":"crossref","first-page":"e98186","DOI":"10.1371\/journal.pone.0098186","article-title":"Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs","volume":"9","author":"Gagnon","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.19_bib37","doi-asserted-by":"crossref","first-page":"24429","DOI":"10.1074\/jbc.M003440200","article-title":"Development and characterization of a recombinant truncated type VII collagen \u201cminigene\u201d. Implication for gene therapy of dystrophic epidermolysis bullosa","volume":"275","author":"Chen","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2016.19_bib38","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/sj.jid.5700435","article-title":"Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients","volume":"126","author":"Goto","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mtna.2016.19_bib39","first-page":"389","article-title":"Construction of first-generation adenoviral vectors","volume":"69","author":"Ng","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1038\/mtna.2016.19_bib40","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/jvi.61.10.3096-3101.1987","article-title":"A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication","volume":"61","author":"Samulski","year":"1987","journal-title":"J Virol"},{"key":"10.1038\/mtna.2016.19_bib41","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mtna.2016.19_bib42","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/jgm.782","article-title":"Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency","volume":"7","author":"Hacker","year":"2005","journal-title":"J Gene Med"},{"key":"10.1038\/mtna.2016.19_bib43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.TP.0000112381.80964.85","article-title":"Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin","volume":"77","author":"Llames","year":"2004","journal-title":"Transplantation"},{"key":"10.1038\/mtna.2016.19_bib44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/10430340252939069","article-title":"A preclinical model for the analysis of genetically modified human skin in vivo","volume":"13","author":"Del Rio","year":"2002","journal-title":"Hum Gene Ther"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311730032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311730032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:25:02Z","timestamp":1761873902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225311730032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":44,"alternative-id":["S216225311730032X"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2016.19","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mtna.2016.19","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Official journal of the American Society of Gene & Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e307"}}